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Stress-induced Alterations in Mast Cell Numbers and Proteinase-
activated Receptor-2 Expression of the Colon: Role of 
Corticotrophin-releasing Factor 
This study was performed in order to assess whether acute stress can increase mast cell and 
enterochromaffin (EC) cell numbers, and proteinase-activated receptor-2 (PAR2) expression 
in the rat colon. In addition, we aimed to investigate the involvement of corticotrophin-
releasing factor in these stress-related alterations. Eighteen adult rats were divided into 3 
experimental groups: 1) a saline-pretreated non-stressed group, 2) a saline-pretreated 
stressed group, and 3) an astressin-pretreated stressed group. The numbers of mast cells, EC 
cells, and PAR2-positive cells were counted in 6 high power fields. In proximal colonic 
segments, mast cell numbers of stressed rats tended to be higher than those of non-
stressed rats, and their PAR2-positive cell numbers were significantly higher than those of 
non-stressed rats. In distal colonic segments, mast cell numbers and PAR2-positive cell 
numbers of stressed rats were significantly higher than those of non-stressed rats. Mast cell 
and PAR2-positive cell numbers of astressin-pretreated stressed rats were significantly 
lower than those of saline-pretreated stressed rats. EC cell numbers did not differ among 
the three experimental groups. Acute stress in rats increases mast cell numbers and mucosal 
PAR2 expression in the colon. These stress-related alterations seem to be mediated by 
release of corticotrophin-releasing factor. 
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INTRODUCTION
Irritable bowel syndrome (IBS) is known to be related to stress, 
which is likely to induce corticotrophin-releasing factor (CRF) 
release (1). CRF family peptides and/or receptors may activate 
immune cells, inducing inflammation via an increase in intesti-
nal permeability or degranulated mast cells (2). Acute stress, 
including water avoidance and immobilization stress, alters in-
testinal motility and increases fecal pellet output in animal stud-
ies. These effects of stress are suggested to be mediated by release 
of CRF (3-5). Furthermore, motility alterations induced by acute 
stress are reported to be blocked by administration of the CRF 
antagonist (3, 6). Stress is implicated in certain neuroinflamma-
tory disorders, such as neurogenic pruritus and interstitial cys-
titis (7). These two diseases are associated with mast cell activa-
tion. Colonic responses to immobilization stress such as mucin 
and prostaglandin E2 release are reported to be related to mast 
cell degranulation (8). 
  Immune activation and mucosal inflammation alter gut mo-
tility, leading to gut dysfunction. Evidence has shown that previ-
ous infection and persistent low-grade inflammation may result 
in gut dysfunction, generating IBS symptoms (9, 10). Increased 
intraepithelial lymphocytes and lamina propria lymphocytes, 
together with elevated numbers of enterochromaffin (EC) cells, 
are observed in patients with post-infectious IBS (11, 12). The 
immune activation is also found in patients with IBS and no his-
tory of previous gastrointestinal (GI) infection. Increased num-
bers of mast cells have been demonstrated in a subset of IBS 
patients without history of previous GI infection as well as post-
infectious IBS patients (12-14). However, the mechanism un-
derlying increased mast cells observed in IBS patients without 
history of previous GI infection remains unclear.
  We hypothesized that CRF released by stress may increase 
the numbers of mast cells in the colon and enhance protease-
activated receptor 2 (PAR2) expression in the colon. Thus, in the 
present study, we aimed to evaluate whether acute restraint 
stress alters the numbers of mast cells and EC cells and PAR2 
expression in the rat colon. This study also aimed to investigate 
the involvement of CRF in these stress-related alterations. 
MATERIALS AND METHODS
Animals 
Eighteen adult male Wistar rats (250-300 g), aged 14-20 weeks, Kim DH, et al.  •  Stress-induced Alterations in the Colon and CRF
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were used for this study. All rats were acclimated for 7 days be-
fore experimentation and allowed free access to food and water. 
Rats were kept on a 12-hr light:dark cycle and isolated from en-
vironmental stressors (e.g., noise) as much as possible. The ani-
mals were housed in pairs in cages and kept in a temperature-
controlled room (21±1°C). All protocols were approved by the 
Institutional Animal Care and Use Committee at Ajou Universi-
ty School of Medicine (AMC-69).
Stress protocol
The rats were handled daily for a week by the same examiner and 
then submitted to acute restraint stress or sham stress for 90 min. 
Rats were divided into 3 experimental groups with 6 rats per treat-
ment group: 1) saline-pretreated non-stressed group (rats were 
pretreated with saline 0.1 mL and then placed freely in their home 
cage for 90 min), 2) saline-pretreated stressed group (rats were 
pretreated with saline 0.1 mL and then placed into the restraint 
tube for 90 min), 3) astressin-pretreated stressed group (rats were 
pretreated with the CRF antagonist astressin, 20 μg/kg in 0.1 mL 
and then placed into the restraint tube for 90 min). In all stress 
sessions, the total body of the animal from head to lower hind-
limbs was tightly placed in a plexiglass cylindrical restrainer for 
immobilization. Restraint stress has been used in visceral hyper-
sensitivity and intestinal permeability studies (15, 16). Partial 
restraint stress model, in which the animal’s fore-shoulders, up-
per fore-limbs and thoracic trunk are restricted for 2 hr, is report-
ed to increase plasma levels of adrenocorticotropic hormone 
and cortisone, which indicates activation of the hypothalamic-
pituitary-adrenal axis (17). We assumed that total restraint could 
cause more stress than partial restraint. Thus, we applied total 
restraint stress for 90 min. Control sham stressed rats were placed 
in their home cages for 90 min without any restraint stress. Fecal 
pellet output is known to increase under stress conditions (18). 
During the experiments, feces were collected. Immediately after 
completing the protocol, all rats were sacrificed by stunning and 
posterior exsanguinations. Just after the sacrifice, blood and tis-
sues were collected. Astressin was purchased from Sigma Chem-
ical Company (St. Louis, MO, USA). 
Measurement of plasma cortisol levels
Blood samples were collected in the central vein immediately 
after completing the experimental protocols and sacrificing rats. 
Blood in a heparinized Eppendorf tube was immediately cen-
trifuged (10,000 rpm, 1 min at 4°C) to separate plasma, which 
was then frozen at –70°C until assay. Plasma cortisol levels were 
quantified using a radioimmunoassay kit (Rat Corticosteroid 
Coat-a-Count Kit, Diagnostic Products Corp., Los Angles, CA, 
USA). 
Histologic studies
Two segments (0.5 cm) of proximal colon, taken from 2 cm from 
the cecocolonic junction, and two distal segments, taken at 2 cm 
from the anorectal junction, were excised for histologic studies. 
Colonic segments were fixed in Carnoy’s solution, cleared in 
xylene, and embedded in paraffin blocks. Paraffin-embedded 
specimens were sliced in 4 µm sections with a microtome, and 
mounted on precoated slides (Dako, Glostrup, Denmark). Fol-
lowing dewaxing, tissue sections were incubated with 0.5% hy-
drogen peroxide in methanol at 22°C for 10 min, and washed 
under running tap water for 15 min. Sections were treated with 
0.1% trypsin (Sigma, Pool, UK) mixed in 0.1% calcium chloride 
(pH 7.8) for 10 min at 37°C. Nonspecific binding was blocked 
by incubation in normal rabbit serum diluted to 1:5 in Tris-buff-
ered saline (TBS; pH 7.6) for 15 min. 
  Toluidine blue staining was performed in order to identify mast 
cell population. The cytoplasm of mast cells contains granules 
(metachromatic) composed of heparin and histamine. Toluidine 
blue stains mast cells red-purple (metachromatic staining) and 
the background blue (orthochromatic staining) (Fig. 1A). Mast 
cells in the mucosa and submucosa were counted in 6 non-over-
lapped high-powered fields (HPF, final magnification, ×400) by 
a pathologist blinded for each experiment.
  The slides were incubated for 18 hr at 4°C with anti-chromo-
granin A antibodies for EC cells and to anti-PAR2 antibodies for 
PAR2 protein expression. Immunostaining was performed as 
previously described using the Dako Techmate 500 Plus and 
Techmate reagents (Dako, Carpinteria, CA, USA). EC cell num-
bers (Fig. 1B) and the levels of PAR2 protein expression (Fig. 1C) 
were assessed 6 non-overlapped HPF by a pathologist in blind. 
Statistical analysis
All data are expressed as means±S.E.M for each group of rats. 
The numbers of mast cells, EC cells, PAR2-positive cells and 
plasma cortisol levels obtained after each treatment were com-
pared using a ANOVA and Student’s t-test. P values <0.05 were 
considered statistically significant. SPSS for Windows version 
11 (SPSS Inc., Chicago, IL, USA) was used for all analyses.
RESULTS
Mast cell and EC cell numbers 
In proximal colonic segments, mast cell numbers of stressed 
rats tended to be higher than those of non-stressed rats (12.7± 
3.5 vs. 4.2±1.1; P=0.06). Mast cell numbers in proximal colonic 
segments of astressin-pretreated stressed rats were significantly 
lower than those of saline-pretreated stressed rats (4.0±1.3 vs. 
12.7±3.5; P=0.05) (Fig. 2A). In distal colonic segments, mast cell 
numbers of stressed rats were significantly higher than those of 
non-stressed rats (18.2±2.7 vs. 10.2±2.1; P=0.04). Mast cell num-
bers in distal colonic segments of astressin-pretreated stressed 
rats were significantly lower than those of saline-pretreated 
stressed rats (7.7±1.9 vs. 18.2±2.7; P=0.01) (Fig. 2B). No signifi-Kim DH, et al.  •  Stress-induced Alterations in the Colon and CRF
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cant differences in EC cell numbers among the three experimen-
tal groups were observed, both in the proximal colonic segments 
(2.0±0.3 vs. 1.7±0.2; P=0.32) (Fig. 3A) and in the distal colonic 
segments (1.5±0.2 vs. 1.3±0.2; P=0.52) (Fig. 3B).
PAR2 expression 
PAR2 protein expression was evaluated by immunohistochem-
istry using a specific monoclonal antibody. PAR2-positive cell 
numbers in proximal colonic segments of stressed rats were 
significantly higher than those of non-stressed rats (34.7±4.7 vs. 
18.8±2.0; P=0.02). PAR2-positive cell numbers in proximal colon-
ic segments of the astressin-pretreated stressed group were sig-
nificantly lower than those of the saline-pretreated stressed group 
(20.5±2.5 vs. 34.7±4.7; P=0.02) (Fig. 4A). PAR2-positive cell num-
bers in distal colonic segments of stressed rats were significant-
ly higher than those of non-stressed rats (55.5±7.0 vs. 31.5±2.9; 
P=0.01). PAR2-positive cell numbers in distal colonic segments 
of the astressin-pretreated stressed group were significantly low-
er than those in the saline-pretreated stressed group (33.8±2.5 
vs. 55.5±7.0; P=0.02) (Fig. 4B). 
Fig. 2. Comparison of mast cell numbers in colonic segments. In proximal colonic segments, mast cell numbers of stressed rats tended to be higher than those of non-stressed 
rats, and mast cell numbers of astressin-pretreated stressed rats were significantly lower than those of saline-pretreated stressed rats (*P=0.05) (A). In distal colonic segments, 
mast cell numbers of stressed rats were significantly higher than those of non-stressed rats (*P=0.04), and mast cell numbers of astressin-pretreated stressed rats were 
significantly lower than those of saline-pretreated stressed rats (
†P=0.01) (B). 
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Fig. 1. Staining of mast cells, EC cells, and PAR2-positive cells (magnification, ×400). 
Toluidine blue stain was performed in order to identify mast cells (A), and immuno- 
staining using anti-chromogranin A antibodies for EC cells (B) and anti-PAR2 antibodies 
for PAR2 protein expression (C) was carried out. Kim DH, et al.  •  Stress-induced Alterations in the Colon and CRF
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Fecal pellet output and plasma cortisol levels
There was significantly higher pellet output in stressed rats com-
pared to non-stressed controls (9.0±0.27 vs. 3.5±0.16; P<0.001). 
Pellet output was significantly reduced by pretreatment of as-
tressin in stressed rats (4.8±0.22 vs. 9.0±0.27; P=0.001). Plasma 
cortisol levels from stressed rats were significantly higher than 
those from non-stressed rats (4.1±0.16 vs. 2.3±0.19 μg/dL; P= 
0.02). Astressin treatment tended to decrease plasma cortisol 
levels in stressed rats (2.9±0.15 vs. 4.1±0.16 μg/dL; P=0.07). 
DISCUSSION
Our results of the present study showed that acute immobiliza-
tion stress increased mast cell numbers and PAR2 expression in 
the colon and these stress effects were inhibited by the CRF an-
tagonist astressin. Thus, these results suggest that CRF released 
by acute stress mediates increase in mast cell numbers and PAR2 
expression. These alterations can lead to increased intestinal 
permeability, inducing inflammation and hypersensitivity of 
the intestine. These stress-induced alterations may explain low-
grade inflammation observed in a subset of IBS patients. Fecal 
pellet output significantly increased in stressed rats, which was 
inhibited by the pretreatment of the CRF antagonist astressin. 
Accordingly, it is conceivable that CRF released by stress plays a 
role in the pathogenesis of IBS. In keeping with our findings, pre-
vious studies have shown that stress can enhance experimental 
colitis, stimulate colonic motility, and induce rectal hyperalge-
sia (2, 5). These effects of stress have suggested to be mediated 
by CRF, the main regulator of the hypothalamic-pituitary-adre-
nal axis (3, 6). CRF receptors are found in different immune cells 
including macrophages, lymphocytes and mast cells (19, 20). 
Thus, these immune cells are likely to be affected by the release 
of CRF. Similarly, it has been shown that CRF released during 
immobilization stress plays a role in increasing colonic transit, 
colonic mucin secretion and the histamine content of colonic 
mast cell (21). 
  Immune activation and mucosal inflammation alter gut motil-
ity and sensitivity. Increased lymphocytes, together with elevat-
ed numbers of mast cells and EC cells, are observed in patients 
with post-infectious IBS (11, 14). In our previous study, we con-
firmed that EC cells, mast cells and lamina propria T lympho-
cytes were definitely increased in patients with post-infectious 
IBS. In that study, we found that mast cells increased in a subset 
of IBS patients without history of previous GI infection (12). Ac-
cordingly, mast cells are likely to be associated with the patho-
genesis of IBS, irrespective of the presence of history of previous 
GI infection. An increase in mast cell density is reported to be 
most remarkable in diarrhea-predominant IBS patients (22). 
Mast cells release potent mediators including tryptase and his-
tamine. These mediators affect the enteric nerves and smooth 
muscle, leading to abnormal secretomotor function and viscer-
al hypersensitivity (23, 24). However, the mechanism underly-
Fig. 4. Comparison of PAR2-positive cell numbers in colonic segments. In proximal colonic segments, PAR2-positive cell numbers of stressed rats were significantly higher than 
those of non-stressed rats (*P=0.02), and PAR2-positive cell numbers of the astressin-pretreated stressed group were significantly lower than those of the saline-pretreated 
stressed group (
†P=0.02) (A). In distal colonic segments, PAR2-positive cell numbers of stressed rats were significantly higher than those of non-stressed rats (*P=0.01), and 
PAR2-positive cell numbers of the astressin-pretreated stressed group were significantly lower than those in the saline-pretreated stressed group (
†P=0.02) (B). 
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Fig. 3. Comparison of EC cell numbers in colonic segments. No significant differences in EC cell numbers among the three experimental groups were observed, both in the 
proximal colonic segments (A) and in the distal colonic segments (B).
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ing increased mast cells observed in IBS patients without histo-
ry of previous GI infection remains unclear. Since stress is known 
to be closely related to IBS, our results of the present study pro-
vide evidence that stress-mediated release of CRF may play a 
role in increasing mast cell number in IBS. In contrast, EC cell 
numbers are not likely to be altered by stress or CRF. 
  PAR2 is a G-protein coupled receptor for trypsin and mast cell 
tryptase. Tryptase released upon mucosal mast cell degranula-
tion can activate PAR2 (26). The results of the present study con-
firmed that PAR2 expression was significantly increased by stress. 
This stress effect was inhibited by the CRF antagonist astressin, 
suggesting the role of CRF. Thus, it is plausible that CRF released 
during acute stress increases mast cell numbers and degranu-
lates mast cells, which upregulates PAR2 expression in the colon. 
PAR2 is highly expressed in the intestine, where it is found in co-
lonic myocytes, enterocytes, enteric neurons, terminals of mes-
enteric afferent nerves, and immune cells (25, 26). Activation of 
PAR2 modulates diverse gastrointestinal functions, such as mo-
tility, ionic exchange, paracellular permeability, sensory func-
tions and inflammation (27). Intracolonic administration of the 
synthetic selective PAR2 agonist in rats increases paracellualr 
permeability and produces visceral hyperalgesia (28). PAR2-
mediated dysfunction of colonic epithelial barrier and subse-
quent allodynia or hyperalgesia may play an important role in 
the pathogenesis of IBS. Actually, elevated colonic luminal ser-
ine protease activity is seen in diarrhea-predominant IBS pa-
tients (29, 30). In mice, colonic exposure to supernatants from 
diarrhea-predominant IBS patients results in allodynia and in-
creased colonic paracellular permeability, which is dependent 
on PAR2 expression (30). 
  The model of total restraint used in the present study produces 
physical stress in addition to psychological stress. Restraint mod-
els have been used in studies on colonic visceral hypersensitivi-
ty and intestinal permeability (15, 16). Our results showed that 
total restraint in rats for 90 min increased plasma cortisol levels, 
suggesting activation of the hypothalamic-pituitary-adrenal axis. 
We speculate that a 90 min restraint session permits the release 
of CRF, which is able to increase mast cells and PAR2 expression 
in the colon. This speculation is of importance in understanding 
the role of stress in triggering IBS symptoms. Indeed, psycho-
logical factors have been suggested to be involved in the patho-
genesis of IBS.    
  In conclusion, acute stress in rats increases mast cell numbers 
and mucosal PAR2 expression in the colon. These stress effects 
seem to be mediated by release of CRF. However, EC cell num-
bers are not likely to be affected by stress or CRF. Increased mast 
cells observed in a subset of IBS patients without history of pre-
vious GI infection may be attributed to stress-induced alterations 
mediated by CRF. 
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